Virtus Investment Advisers, Inc. Belite Bio, Inc Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Belite Bio, Inc stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 1,513 shares of BLTE stock, worth $111,250. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,513
Previous 2,589
41.56%
Holding current value
$111,250
Previous $171,000
49.12%
% of portfolio
0.03%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding BLTE
# of Institutions
18Shares Held
76.3KCall Options Held
0Put Options Held
0-
State Street Corp Boston, MA20.2KShares$1.49 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12.9KShares$945,8890.0% of portfolio
-
Marshall Wace, LLP London, X09.49KShares$697,5050.0% of portfolio
-
Jpmorgan Chase & CO New York, NY8.16KShares$600,1510.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.46KShares$548,2390.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $1.83B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...